Lipocine Inc. (LPCN) — Analyst outlook / Analyst consensus target is. Based on 9 analyst ratings, the consensus is bullish — 7 Buy, 2 Hold.
The consensus price target is $15.00, representing an upside of 485.9% from the current price $2.56.
Analysts estimate Earnings Per Share (EPS) of $-0.73 and revenue of $0.01B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.00 vs est $-0.73 (beat +100.2%). 2025: actual $-1.77 vs est $-1.97 (beat +9.9%). Analyst accuracy: 0%.
LPCN Stock — 12-Month Price Forecast
$15.00
▲ +485.94% Upside
Average Price Target
Based on 9 Wall Street analysts offering 12-month price targets for Lipocine Inc., the price target is $15.00.
The average price target represents a +485.94% change from the last price of $2.56.
LPCN Analyst Ratings
Buy
Based on 9 analysts giving stock ratings to Lipocine Inc. in the past 3 months
EPS Estimates — LPCN
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.00
vs Est –$0.73
▲ 45,725.0% off
2025
Actual –$1.77
vs Est –$1.97
▲ 11.0% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. Analysts expect losses to continue near-term.
Revenue Estimates — LPCN
70%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $0.011B
vs Est $0.010B
▲ 7.8% off
2025
Actual $0.002B
vs Est $0.001B
▲ 52.1% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
